Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine - A combined analysis of five phase III clinical trials.
about
Expanded strain coverage for a highly successful public health tool: prophylactic 9-valent human papillomavirus vaccine.Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development.Efficacy, Immunogenicity, and Safety of a 9-Valent Human Papillomavirus Vaccine: Subgroup Analysis of Participants From Asian Countries.
P2860
Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine - A combined analysis of five phase III clinical trials.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Impact of baseline covariates ...... ive phase III clinical trials.
@en
type
label
Impact of baseline covariates ...... ive phase III clinical trials.
@en
prefLabel
Impact of baseline covariates ...... ive phase III clinical trials.
@en
P2093
P2860
P50
P1476
Impact of baseline covariates ...... ive phase III clinical trials.
@en
P2093
Alain Luxembourg
Anna R Giuliano
Daron Ferris
Donna Hyatt
Elmar A Joura
Erin Moeller
Jack Cuzick
Jaime Restrepo
Lone K Petersen
P2860
P304
P356
10.1016/J.PVR.2017.03.002
P577
2017-03-16T00:00:00Z